APA

Dinçel C., Caşkurlu T., Taşçi A. I., Cek M., Sevin G. & Fazlioğlu A. (20000218). Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels. : International urology and nephrology.

Chicago

Dinçel C, Caşkurlu T, Taşçi A I, Cek M, Sevin G and Fazlioğlu A. 20000218. Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels. : International urology and nephrology.

Harvard

Dinçel C., Caşkurlu T., Taşçi A. I., Cek M., Sevin G. and Fazlioğlu A. (20000218). Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels. : International urology and nephrology.

MLA

Dinçel C, Caşkurlu T, Taşçi A I, Cek M, Sevin G and Fazlioğlu A. Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels. : International urology and nephrology. 20000218.